In autoimmune diseases, IL-1R2 can control IL-1-driven inflammatory responses and serves as an important internal brake in the later stages of the immune response, limiting IL-1-dependent B cell activation and germinal center reactions, as well as antibody production [58,59]. Here, IL1R2 is linked to autoimmune disease.